Automating MEDITECH Yervoy Prior Authorization Workflows

Klivira streamlines the complex process of MEDITECH Yervoy prior authorization, ensuring timely approvals for this critical immunotherapy in community hospital settings.

For revenue cycle leaders and prior authorization teams utilizing MEDITECH, managing high-volume, high-cost drug PAs like Yervoy presents significant operational challenges. Klivira offers a robust solution to automate data extraction, submission, and status tracking, reducing administrative burden and accelerating patient access to care.

Navigating Yervoy Prior Authorization within MEDITECH Environments

Yervoy (ipilimumab) is a critical immunotherapy often requiring prior authorization across commercial, Medicare Advantage, and Medicaid managed care plans. Its administration typically involves a medical benefit claim, although specialty pharmacy coordination is often integral. Klivira addresses the complexities of managing these workflows directly within MEDITECH, recognizing the distinct integration surfaces and user experiences across MEDITECH Expanse, 6.x, and legacy Magic/C/S product lines.

Klivira's Integration with MEDITECH for Yervoy PA Automation

Klivira leverages MEDITECH's modern integration capabilities, primarily focusing on Expanse APIs, FHIR R4, and SMART App Launch, to extract necessary clinical documentation. For environments with legacy MEDITECH systems (Magic, C/S, 6.x), our solutions also accommodate HL7 v2 interfaces, ensuring comprehensive data capture regardless of your MEDITECH product line. This technical flexibility is crucial for automating the MEDITECH Yervoy prior authorization process.

Key Data Points Klivira Extracts from MEDITECH for Yervoy PAs

Patient demographics and insurance information (via US Core FHIR resources or HL7 ADT messages)
Clinical notes and supporting documentation from the Documentation module
Problem lists, diagnosis codes, and relevant lab results
Yervoy order details from the Orders activity
Medication history and prior therapy details

Managing Yervoy's Medical and Pharmacy Benefit PA Split

While Yervoy is predominantly a medical benefit drug, its high cost and specialized nature often involve specialty pharmacy oversight. Klivira's platform is designed to identify the appropriate benefit pathway (medical vs. pharmacy benefit) and streamline the prior authorization submission accordingly, whether through X12 278 transactions for medical or NCPDP SCRIPT for pharmacy benefit, where applicable. This ensures accurate and efficient routing for Yervoy PAs.

Streamlining Specialty Pharmacy Workflows in MEDITECH

For Yervoy and similar specialty drugs, efficient coordination with specialty pharmacies is paramount. Klivira integrates with MEDITECH to automate the exchange of necessary clinical and authorization data, facilitating smooth handoffs to specialty pharmacies. Our solution helps ensure that all required documentation for specialty pharmacy dispensing is readily available and communicated, reducing delays in patient access to vital treatments.

The Klivira Advantage for MEDITECH Yervoy PAs

By automating MEDITECH Yervoy prior authorization, Klivira significantly reduces the manual burden on PA coordinators and clinical staff. Our platform minimizes data entry errors, accelerates submission times, and provides transparent status tracking, ultimately improving approval rates and patient satisfaction. We help community hospitals optimize their revenue cycle by streamlining the PA process for high-value immunotherapies like Yervoy.

Frequently asked questions

How does Klivira integrate with MEDITECH for Yervoy prior authorizations?

Klivira integrates with MEDITECH primarily through Expanse APIs, leveraging FHIR R4 and SMART App Launch for robust data exchange. For organizations operating older MEDITECH versions (6.x, Magic, C/S), we also support HL7 v2 interfaces to ensure comprehensive data extraction, adapting to the specific integration surface of each customer's environment.

Can Klivira handle both medical and pharmacy benefit prior authorizations for Yervoy in MEDITECH?

Yes, Klivira is designed to manage prior authorizations for Yervoy regardless of whether it falls under medical or pharmacy benefits. Our platform intelligently routes the PA request through the appropriate channels, whether it's an X12 278 transaction for medical claims or a NCPDP SCRIPT for pharmacy benefits, ensuring compliance and efficiency.

What specific data does Klivira pull from MEDITECH to support Yervoy PAs?

Klivira extracts a comprehensive set of clinical data from MEDITECH to support Yervoy prior authorizations. This includes patient demographics, diagnosis codes, problem lists, relevant lab results, order details for Yervoy, and clinical notes from the documentation modules, all critical for demonstrating medical necessity.

How does Klivira address the different MEDITECH product lines (Expanse, 6.x, Magic)?

We acknowledge the significant variability across MEDITECH product lines. Klivira's integration strategy prioritizes the modern Expanse APIs (FHIR, SMART App Launch) for optimal functionality. For legacy systems, we adapt by utilizing established HL7 v2 interfaces and working with customer-specific configurations to ensure effective data flow and PA workflow automation.

Does Klivira write back PA status updates to MEDITECH?

Yes, where MEDITECH's write APIs are available and verified for a specific customer's product line, Klivira can write back prior authorization status updates directly into the EMR. This functionality helps keep clinical and administrative staff informed within their native MEDITECH workflows, reducing the need to toggle between systems.